Breast Cancer
Latest News
Novel trastuzumab duocarmazine significantly improved survival in advanced HER2-positive breast cancer
Trastuzumab duocarmazine is a novel HER2-targeting antibody-drug conjugate which, according to the results of the TULIP trial recently presented...
Conference Coverage
Treatment shows 'important improvements' in triple-negative breast cancer
Survival of patients without an initial diagnosis of triple-negative breast cancer was better with the antibody-drug conjugate, compared with...
From the Journals
Better survival with extended letrozole in early-stage breast cancer
Guidelines for duration of endocrine therapy ‘should be updated.’
Conference Coverage
TULIP trial shows extended survival in HER2+ metastatic breast cancer
Progression-free survival was up to 7 months in some cases, but with adverse events.
Conference Coverage
Study supports add-on therapy for germline and wildtype BRCA mutations
The findings put to rest the notion that patients with germline BRCA mutations would not benefit from carboplatin treatment because of sensitivity...
Conference Coverage
Twelve-month overall survival benefit with ribociclib for metastatic breast cancer
It’s the first phase 3 trial to report a median overall survival beyond 5 years in advanced breast cancer.
Latest News
Call for a move or boycott of big Texas cancer meeting
“I think that if Texas officials understood that when they pass laws inhospitable to women, we will not hold a major conference about women’s...
Latest News
Patients panic as docs cut off breast cancer drug
Experts say discontinuing atezolizumab is not advised if a patient is responding or is stable.
Latest News
Flurry of cancer drug endorsements from EU panel
Approvals include pralsetinib for non-small cell lung cancer, ripretinib for advanced gastrointestinal stromal tumor, and zanubrutinib for...
From the Journals
Immunotherapy for cancer patients with poor PS needs a rethink
Patients should not receive immunotherapy just to reduce risk of side effects, doctor says.
From the Journals
Breast density associated with increased invasive breast cancer risk after age 65
Breast density and life expectancy should be considered together when making decisions about mammography screening in older women.